27. Adélaïde, L., et al. (2024). Environmental and social inequities in continental France: An analysis of exposure to heat, air pollution, and lack of vegetation. Journal of Exposure Science & Environmental Epidemiology, 34(6), 962–972. https://pubmed.ncbi.nlm.nih.gov/38279031/ 28. Direction de la recherche, des études, de l’évaluation et des statistiques (DREES). (2022, October). Chronic diseases more often affect those on low incomes and more significantly reduce their life expectancy. DREES, Études et Résultants, no. 1243. https://drees.solidarites-sante.gouv.fr/sites/default/files/2023-04/ER1243ENMAJ0704-23.pdf 29. World Health Organization. (2022). WHO report on the global tobacco epidemic 2021: Addressing new and emerging products. https://www.who.int/publications/i/item/9789240032095 30. Grea, C., et al. (2024). Produktmonitoring 2023: Ergebnisbericht [in German]. https://doi.org/10.25826/20240409- 154038-0 31. Organisation for Economic Co-operation and Development (OECD)/European Observatory on Health Systems and Policies. (2023). Greece: Country health profile 2023, state of health in the EU. https://www.oecd.org/en/ publications/2023/12/greece-country-health-profile-2023_0d70aae7.html 32. Organisation for Economic Co-operation and Development (OECD)/European Commission (2024). Health at a glance: Europe 2024: State of health in the EU cycle. https://doi.org/10.1787/b3704e14-en. 33. Ministry of Health Italy. (2024). National cancer screening data 2019–2023. 34. Ministry of Health, Labour and Welfare (MHLW). (2023). National health and nutrition survey 2022. https://www.mhlw. go.jp/content/10900000/001296359.pdf 35. Sayani, A., et al. (2021). Advancing health equity in cancer care: The lived experiences of poverty and access to lung cancer screening. PLOS ONE, 16(5), e0251264. https://doi.org/10.1371/journal.pone.0251264 36. Organisation for Economic Co-operation and Development (OECD) and European Commission. (2024). Health at a glance: Europe 2024: State of health in the EU cycle. OECD Publishing, Paris. https://doi.org/10.1787/b3704e14-en. 37. Tangri, N., et al. (2023). Prevalence of undiagnosed stage 3 chronic kidney disease in France, Germany, Italy, Japan and the USA: results from the multinational observational REVEAL-CKD study. BMJ Open, 13(5), e067386. https://doi. org/10.1136/bmjopen-2022-067386 38. World Health Assembly. (2025). Promoting and prioritizing an integrated lung health approach. World Health Organization. https://apps.who.int/gb/ebwha/pdf_files/WHA78/A78_R5-en.pdf 39. World Health Organization (2025, December 8). Political declaration of the fourth high-level meeting of the General Assembly on the prevention and control of noncommunicable diseases and the promotion of mental health and well- being. https://docs.un.org/en/A/80/L.34 40. Ndumele, C. E., et al, on behalf of the American Heart Association. (2023). Cardiovascular-kidney-metabolic health: A presidential advisory from the American Heart Association. Circulation, 148(20), 1606–1635. https://doi.org/10.1161/ CIR.0000000000001184 41. Kowalska-Bobko, I., et al. (2025). Policy roadmap for acting early on NCDs: Poland. Partnership for Health System Sustainability and Resilience (PHSSR). https://www.phssr.org/research 42. Ministry of Health, Labour and Welfare (MHLW). (2023). Report of specific health checkup and health guidance, fiscal year 2022. https://www.mhlw.go.jp/content/12400000/001483522.pdf 43. Deutsches Krebsforschungszentrum. (2024). Krebsvorsorge und Krebsfrüherkennung [in German]. https://www. krebsinformationsdienst.de/krebsvorsorge-und-krebsfrueherkennung 44. Tillmanns, H., et al. (2022). Inanspruchnahme von Früherkennungsleistungen der gesetzlichen Krankenversicherung durch AOK-Versicherte im Erwachsenenalter 2007 bis 2021 [in German]. https://www.wido.de/fileadmin/Dateien/Bilder/ Forschung_Projekte/Ambulante_Versorgung/Frueherkennung_bei_Erwachsenen_2007_2021.pdf 45. ESC Cardiovasc Risk Collaboration, & SCORE2 Working Group. (2021). SCORE2 risk prediction algorithms: New models to estimate 10-year risk of cardiovascular disease in Europe. European Heart Journal, 42(25), 2439–2454. https://academic.oup.com/eurheartj/article/42/25/2439/6297709 46. Organisation for Economic Co-operation and Development (OECD)/European Commission. (2024). Greece: country health profile 2023, state of health in the EU. https://www.oecd.org/content/dam/oecd/en/publications/reports/2023/12/ greece-country-health-profile-2023_0d70aae7/dd530c3e-en.pdf 47. Universitat Oberta de Catalunya. (2022, April 22). La historia clínica electrònica en la UE: La historia clínica electronica todavía no es una realidad e la Unión Europea [in Spanish]. https://www.uoc.edu/es/news/2022/096-historia-clinica-europa 48. Gitt, A. K., et al. (2016). Better lipid target achievement for secondary prevention through disease management programs for diabetes mellitus and coronary heart disease in clinical practice in Germany. Current Medical Research and Opinion, 32(3), 417–426. https://pubmed.ncbi.nlm.nih.gov/26568400/ 49. Kostev, K., et al. (2017). Impact of disease management programs on HbA1c values in type 2 diabetes patients in Germany. Journal of Diabetes Science and Technology, 11(1), 117–122. https://pubmed.ncbi.nlm.nih.gov/27246670/ 50. Wangler, J., & Jansky, M. (2021). Attitudes to and experience of disease management programs in primary care – an exploratory survey of general practitioners in Germany. Wiener Medizinische Wochenschrift, 171(13–14), 310–320. https://pubmed.ncbi.nlm.nih.gov/34338907/ Acting Early on Non-Communicable Diseases: A Framework for Health System Transformation 29

Acting Early on Non-Communicable Diseases 2026